The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
27-Nov-19
$320 million
Target:
David’s Bridal Inc.
Acquiror:
N/A
Advised David’s Bridal, a leading bridal gown and special occasion dress retailer, on its out-of-court recapitalization
17-Oct-19
$400 million
Target:
Marshall Retail Group
Acquiror:
WH Smith plc
Advised WH Smith PLC, one of the UK’s leading retailers, on the proposed acquisition of Marshall Retail Group, a market leading US travel retailer with operations across airport, resort and tourist locations, from Brentwood Associates, a consumer-focused private equity firm
22-Feb-19
$1.6 billion
Target:
Dairy Crest Group plc
Acquiror:
Saputo Inc.
Advised Dairy Crest Group plc, a producer of leading British food brands and value-added ingredients, on a recommended cash offer for its entire issued share capital from Saputo Inc, one of the top ten dairy processors in the world
28-Jan-19
$NA
Target:
The Laundress Inc.
Acquiror:
Unilever plc
Advised The Laundress Inc., a laundry and home cleaning products brand, on its sale to Unilever, a British-Dutch consumer goods company
19-Dec-18
$NA
Target:
Pfizer Inc. Consumer Health Business
Acquiror:
GlaxoSmithKline plc
Advised GlaxoSmithKline plc ("GSK"), the UK listed international pharmaceutical and consumer healthcare company, on the combination of GSK's and Pfizer's Consumer Health businesses to create a world-leading Joint Venture
03-Dec-18
$4.0 billion
Target:
Assets owned by GlaxoSmithKline plc
Acquiror:
Unilever plc / Hindustan Unilever Limited
Advised GlaxoSmithKline plc, the UK listed international pharmaceutical and consumer healthcare company, on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc, and on the merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited
18-Nov-18
$876 million
Target:
David's Bridal
Acquiror:
N/A
Advised the Ad Hoc Group of the company's $481mm term loan with respect to the company's prepackaged Chapter 11 restructuring
30-Oct-18
$198 million
Target:
InMotion Entertainment Group LLC
Acquiror:
WH Smith plc
Advised WH Smith plc, one of the UK’s leading retailers, on the acquisition of InMotion Entertainment, the market leading retailer of digital accessories in US airports
15-Oct-18
$1.1 billion
Target:
Greencore Group plc’s US business
Acquiror:
Hearthside Food Solutions LLC
Advised and acted as sponsor to Greencore Group plc, a leading international manufacturer of convenience foods based in Ireland, on the disposal of its entire US business to Hearthside Foods Solutions
04-Oct-18
$154 million
Target:
Larger non-controlled assets of Electra Private Equity plc
Acquiror:
Lexington Partners
Advised Electra Private Equity plc, a UK-listed private equity investment trust, on its strategic review and subsequent sale of the larger non-controlled assets of Photobox and Knight Square to funds managed by Lexington Partners
23-May-18
$93 million
Target:
Dairy Crest Group PLC
Advised Dairy Crest, a leading British dairy company, on a non-pre-emptive cash placing, raising proceeds of approximately £70 million
07-May-18
$7.1 billion
Target:
Frutarom
Acquiror:
International Flavors and Fragrances
Advised IFF, a leading innovator of specialty ingredients, on its acquisition of Frutarom, creating a global leader in Taste, Scent and Nutrition
02-May-18
$3.7 billion
Target:
Concordia International Corp.
Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt
27-Mar-18
$13.0 billion
Target:
Novartis AG’s 36.5% stake in Consumer Health Joint Venture
Acquiror:
GlaxoSmithKline plc
Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture
26-Mar-18
$284 million
Target:
Grupo Rudelman
Acquiror:
Inchcape PLC
Advised Inchcape PLC, a global leader in automotive and distribution, on the acquisition of Grupo Rudelman, a Suzuki-focused distribution business in Costa Rica and Panama
31-Oct-17
$2.0 billion
Target:
Hirslanden Private Hospital Group
Advised Hirslanden Private Hospital Group, Switzerland's largest private hospital group and a wholly-owned subsidiary of Mediclinic International Plc, on the refinancing of its CHF 2.0 billion senior secured bank debt
02-Oct-17
$NA
Target:
Mãe Terra Produtos Naturais Ltda.
Acquiror:
The Unilever Group
Advised Mãe Terra Produtos Naturais Ltda., Brazil’s leading Natural & Organic food products company, on its sale to The Unilever Group
11-May-17
$245 million
Target:
Equity stake in Bupa Arabia
Acquiror:
Bupa Ltd.
Advised Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, one of the largest health insurance providers in the Kingdom of Saudi Arabia
27-Jan-17
$4.6 billion
Target:
Booker Group plc
Acquiror:
Tesco plc
Advised Tesco plc, the UK’s leading retailer, on its merger with Booker Group plc, the UK’s leading food wholesaler, to create the UK’s leading food business
22-Dec-16
$290 million
Target:
Subsidiaries and affiliates of Empresas Indumotora S.A.
Acquiror:
Inchcape PLC
Advised Inchcape PLC, a global leader in automotive retail and distribution, on the acquisition of a multi-country scale distribution business in Chile, Peru, Colombia, and Argentina for $290m (approximately £234m)
14-Nov-16
$748 million
Target:
Peacock Foods
Acquiror:
Greencore Group plc
Advised Greencore Group plc, a leading international manufacturer of convenience foods based in Ireland, on the proposed acquisition of Peacock Foods, a manufacturing partner for consumer packaged goods companies in the US.
05-Oct-16
$NA
Target:
Portfolio of 14 Outlicensing generic products in the EEA from Teva Pharmaceutical Industries Ltd.
Acquiror:
Accord Healthcare Ltd.
Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of 14 Outlicensing pharmaceutical products in the EEA to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited).
05-Oct-16
$775 million
Target:
Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.
Acquiror:
Accord Healthcare Ltd.
Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m)
04-Oct-16
$223 million
Target:
U.S. rights to Toprol-XL (AstraZeneca)
Acquiror:
Aralez Pharmaceuticals Inc.
Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the U.S. rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.
17-Jun-16
$310 million
Target:
Dobbies Garden Centres
Acquiror:
Investor group led by Midlothian Capital Partners and Hattington Capital
Advised Tesco plc, a listed FTSE 100 retailer, on its sale of Dobbies Garden Centres to an investor group led by Midlothian Capital Partners and Hattington Capital